Navigation

Asthma (in adults) - corticosteroids

Corticosteroids for the treatment of chronic asthma in adults and children aged 12 years and over

Status: History
Expected date of issue: March 2008
Process: MTA
Topic area:
  • Respiratory
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Elangovan Gajraj
Communications manager: Phil Ranson
Project manager: Eloise Saile
Assessment Group / Evidence Review Group: Southampton Health Technology Assessment Centre (SHTAC), University of Southampton
Top


 

Provisional schedule

Consultation on draft scope by stakeholders: December 2005
Information meeting with consultees: 28 April 2006
Closing date for invited submissions / evidence submission: 26 July 2006
Final scope published: February 2006
1st appraisal committee meeting: 28 March 2007
2nd appraisal committee meeting: 27 June 2007
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Altana Pharma Ltd
  • AstraZeneca UK Ltd
  • GlaxoSmithKline UK Ltd
  • IVAX Pharmaceuticals UK Ltd
  • Ranbaxy UK Limited
  • Trinity-Chiesi Pharmaceuticals Ltd
  • Viatris Pharmaceuticals Ltd

Patient / Carer Groups

  • Action Against Allergy (AAA)
  • Allergy UK
  • Asthma UK
  • British Lung Foundation

Professional Groups

  • British Paediatric Respiratory Society
  • British Thoracic Society
  • Cochrane Airways Group
  • Education for Health
  • General Practice Airways Group (GPIAG)
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Physicians
  • Royal College of Physicians of Edinburgh
  • Royal Pharmaceutical Society

Others

  • Department of Health
  • Welsh Assembly Government

General

  • British National Formulary
  • Medicines and Healthcare products    Regulatory Agency (MHRA)
  • NHS Confederation
  • NHS Quality Improvement Scotland

Comparator Manufacturers

  • AstraZeneca UK Ltd
  • GlaxoSmithKline UK Ltd
  • IVAX Pharmaceuticals UK Ltd
  • Merck Pharmaceuticals Ltd
  • Napp Pharmaceuticals Ltd (oral theophyllines)
  • Ranbaxy UK Limited
  • TEVA UK Ltd
  • Trinity-Chiesi Pharmaceuticals Ltd
  • Viatris Pharmaceuticals Ltd

Assessment Team

  • National Coordinating Centre for Health Technology Assessment
  • Southampton Health Technology Assessment Centre (SHTAC), University of Southampton

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Research Groups

  • Asthma And Allergy Research Group, University of Dundee
  • Respiratory Research Group, University of Glasgow

Top


 

Project history

Date Update
8 June 2005 Topic summary published.
16 March 2006 Final matrix of consultees published.
7 September 2007 Project Manager changed to Eloise Saile
5 February 2007 Executive Lead changed to Peter Littlejohns
29 February 2008 Technical Lead changed to Elangovan Gajraj
Top


 

Key documents

This page was last updated: 23 August 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.